
Alzheimer’s Association International Conference 2024 (AAIC 2024)
Philadelphia, Pennsylvania, US 28 July 2024 - 01 August 2024
Sildenafil shows promise as treatment for Alzheimer’s disease
15 Aug 2024
byStephen Padilla
Sildenafil, a phosphodiesterase type 5 inhibitor, can be a potential treatment for Alzheimer’s disease (AD), as shown in real-world data, AD patient-induced pluripotent stem cells (iPSC)-derived neuron models, and in vivo transgenic mouse model observations, according to a study presented at AAIC 2024.
15 Aug 2024

Blood test delivers precision to AD diagnosis in primary, secondary care
12 Aug 2024
byJairia Dela Cruz
A blood test for identifying Alzheimer’s disease (AD) among individuals with cognitive symptoms appears to be highly accurate, outperforming traditional methods used in the primary and secondary care settings, according to a study.
12 Aug 2024




